Xcout Intel
Convergent Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Convergent Therapeutics, Inc. among biopharmaceutical companies — ranked by similarity to what Convergent Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Convergent Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. is a biotechnology research company based in Cambridge, Massachusetts, focused on developing next-generation targeted radiotherapies and combination therapies to treat cancer.
Convergent Therapeutics, Inc. at a glance
Convergent Therapeutics, Inc. is a biopharmaceutical company headquartered in United States. Its most recent funding round, Series A, raised $40M in September 2024. Xcout tracks 9 named people at Convergent Therapeutics, Inc., including Alex Brown (Chief Operating Officer).
Convergent Therapeutics, Inc. leadership
- Alex BrownChief Operating Officer
- Eric M. SullivanChief Financial Officer
- Andrew DavisChief Business and Strategy Officer
- Elizabeth L. MontgomeryChief People Officer
- Dr. Philip KantoffChief Executive Officer, Co-Founder
- Dr. Neil BanderSenior Scientific Advisor, Co-Founder
3 more named people on record for Convergent Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Convergent Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | 4 named | |
| SEC Form D filing | $22.2M | — | |
| SEC Form D filing | $29.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Convergent Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Convergent Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biopharmaceuticals
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Biopharmaceuticals
Fusion Pharmaceuticals is a pharmaceutical company focused on developing targeted radiopharmaceuticals for the treatment of cancer patients.
Biopharmaceuticals
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for oncology and is based in Toronto, Canada, with a corporate office in Boston, Massachusetts.
Drug Discovery
Cognito Therapeutics Ltd. is a clinical-stage company headquartered in Cambridge, Massachusetts, that has conducted multiple clinical studies for its therapeutic products.
Biopharmaceuticals
Citius Oncology is a biopharmaceutical company that develops and commercializes targeted oncology therapies. It serves patients with cancer, including its FDA-approved targeted immune therapy LYMPHIR for cutaneous T-cell lymphoma.
Drug Discovery
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Biopharmaceuticals
Lifordi Immunotherapeutics, Inc. is a clinical-stage biotechnology company based in Burlington, Massachusetts, focused on developing antibody-drug conjugates (ADCs).
Drug Discovery
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Drug Discovery
Arc Therapeutics partners with hospitals to establish specialty centers for the management and treatment of metastatic brain tumors. The company provides turnkey radiosurgical solutions, including the installation of Zap-X radiosurgical units, facility design, financial and operational support, clinical training, and multidisciplinary care coordination for cancer patients.
Drug Discovery
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Biopharmaceuticals
Intarcia Therapeutics, Inc. is a biopharmaceutical research company headquartered in Boston, Massachusetts, focused on developing treatments in various therapeutic areas.
Drug Discovery
Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Convergent Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Convergent Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →